Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.
Stocks · News reference
Companies Reporting Before The Bell • MillerKnoll (NASDAQ:MLKN) is likely to report quarterly earnings at $0.35 per share on revenue of $943.18 million. • AutoZone (NYSE:AZO) is estimated to report quarterly earnings
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.
Ascendiant Capital analyst Edward Woo maintains Aytu BioPharma (NASDAQ:AYTU) with a Buy and raises the price target from $14.5 to $15.
Aytu BioPharma reported a Q4 loss of $0.05 per share, beating consensus estimates of -$0.22 loss, representing a 77.27% earnings surprise. The company posted revenues of $16.11 million, surpassing consensus by 39.45%. However, the stock has underperformed the market, down 18.3% year-to-date versus the S&P 500's 13.4% gain. The company holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions.
On Tuesday, Aytu BioPharma (NASDAQ:AYTU) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time
Records from October 14, 2026 indicate that Representative Rick Allen of Georgia made a sale of AutoZone (NYSE:AZO), valued between $16,002 and $65,000, with the transaction dated September 22, 2026 and filed in
Filed: 2026-10-09 AccNo: 0001171843-26-006565 Size: 180 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers